The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.9 pts more than Nifty Microcap 250 and 7.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Virupaksha Organics Ltd, part of the promoter group of Oxygenta Pharmaceutical Ltd, has acquired 50,88,800 shares (13.76%) of the company through a voting rights transaction. Before this acquisition, the acquirer held 27,79,340 shares (7.51%); after the deal, its total holding has risen to 78,68,140 shares, or 21.27% of the paid-up share capital. The shares were acquired outright with no encumbrance (pledge/lien) involved. The disclosure was filed with BSE on April 24, 2025, by Chandra Mouliswar Reddy Gangavaram on behalf of the acquirer.
This is a significant promoter-group stake increase that strengthens the promoters' control in Oxygenta Pharmaceutical by pushing their holding past the 20% mark, which may be viewed positively by retail investors as a sign of promoter confidence but also raises open-offer implications depending on the mode of acquisition.